Bausch + Lomb Corp sees mixed performance amid leadership changes and revenue guidance updates.
This week, Bausch + Lomb Corp (BLCO.TO) experienced a slight uptick of 1.62% on Tuesday, although it remains down 1.65% over the past week. The stock is currently trading at C$23.41, reflecting a year-to-date increase of 2.11%. Recent news regarding executive appointments and updated revenue guidance has drawn attention to the stock's potential.
Advertisement
Bausch + Lomb Corp
BLCO.TO
BLCO.TO
Bausch + Lomb Corp
WealthAwesomeAdvertisement
Market cap
$8.31B
52W high
$25.70
52W low
$18.76
1W change
-1.06%
Beta
0.55
Analyst Price Targets
Based on analyst covering BLCO
Wall Street analysts forecast BLCO stock price to rise 7.7% over the next 12 months.
Consensus
Moderately BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.22
+7.7% Upside
Current Price
C$23.41
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BLCO's historical volatility
30-Day Vol
34.2%
Annualized
90-Day Vol
29.3%
Annualized
Trend (90d)
+21.0%
Annualized drift
90d Mean
C$25.23
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$24.00 | C$21.33 – C$27.01 |
| 60 trading days | C$24.61 | C$20.82 – C$29.08 |
| 90 trading days | C$25.23 | C$20.56 – C$30.96 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should consider the implications of the recent leadership changes and revenue guidance updates on Bausch + Lomb's future performance. While the stock shows some technical strength, its fundamentals indicate challenges that may impact long-term growth.
C$23.41
Bausch + Lomb's stock is currently trading 4.4% above its 50-day moving average, indicating a potentially positive short-term trend.
Bull case
The appointment of Thomas J. Appio to the board could signal a strategic shift aimed at improving performance. This change, along with the raised revenue guidance, suggests that the company is positioning itself for growth in the competitive health care sector.
Bear case
Despite the positive news, Bausch + Lomb's negative profit margin and return on equity raise concerns about its financial health. While the stock's beta of 0.55 indicates lower volatility, this could also limit potential upside compared to higher-risk investments.
Price Action Overview
Advertisement
Bausch + Lomb Corp (BLCO.TO) closed at C$23.41 on Tuesday, marking a 1.62% increase for the day. However, the stock remains down 1.65% for the week, reflecting a slight struggle in maintaining momentum. Year-to-date, Bausch + Lomb has gained 2.11%, indicating a generally stable performance in the health care sector.
Recent Company News
Recent headlines surrounding Bausch + Lomb include the appointment of Bausch Health CEO Thomas J. Appio to its board, which may signal a renewed focus on strategic growth. Furthermore, the company has reaffirmed its guidance following an upward revision of its revenue outlook for 2026. These developments may positively influence investor sentiment, as they suggest a proactive approach to navigating market challenges.
Technical Picture
From a technical standpoint, Bausch + Lomb is currently trading at C$23.41, which is 4.4% above its 50-day moving average of C$22.42 and 3.3% above its 200-day moving average of C$22.66. The stock's 52-week range spans C$18.76 to C$25.70, indicating it is currently trading at 67% of its range. With a beta of 0.55, the stock exhibits lower volatility compared to the market, which may appeal to risk-averse investors. The latest trading volume of 2,011 shares slightly exceeds the 20-day average volume of 1,903 shares, suggesting a modest uptick in interest.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
